Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Academisch Ziekenhuis Leiden A/U Leiden University Medical Center manages a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. The portfolio currently includes 1 pending office action. This active matter reflects the institution's efforts to protect its medical and biotechnological research. The prosecution activity is focused on this outstanding filing.
The prosecution is handled by 1 distinct examiner and 1 distinct art unit. This indicates that the portfolio's active matters are being reviewed in the assigned administrative environment. For practitioners, this means that the prosecution outcome is dependent on the views of the examiner. There is no variation in examination style across the current pending workload.
LEONARD, ARTHUR S is the busiest examiner for this portfolio, overseeing 1 busiest examiner pending office action. As this matches the total of 1 pending office action, this examiner is the official currently reviewing the institution's active filings. Practitioners should tailor their arguments to the technical expertise of LEONARD, ARTHUR S in the Biotechnology & Pharmaceuticals sector.
The alignment of 1 distinct art unit with the Biotechnology & Pharmaceuticals area provides the prosecution landscape. With 1 pending office action, the institution can ensure that its legal strategy is executed. This approach reduces the administrative overhead associated with managing a portfolio of medical research.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEONARD, ARTHUR S | 1 | 50.5% | +50.4% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17366662 | MODULATION OF CILIOGENESIS | LEONARD, ARTHUR S | — |
| Art Unit | Apps |
|---|---|
| 1631 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17366662 | MODULATION OF CILIOGENESIS | LEONARD, ARTHUR S | 1631 | §112DP | Non-Final OA | — | Pending | Jul 02, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAcademisch Ziekenhuis Leiden A/U Leiden University Medical Center has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Arthur S Leonard has the most, with 1 of Academisch Ziekenhuis Leiden A/U Leiden University Medical Center's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
